HYBRIDGE

About

Why HYBRIDGE exists

Scientist in gloves using tweezers to handle assorted pills in a petri dish.
Photo by www.kaboompics.com on Pexels
Close-up of laboratory equipment with capsules, capturing pharmaceutical analysis.
Photo by Pilan Filmes on Pexels
Close-up of microscope on desk in a modern laboratory with scientist working in the background.
Photo by Tima Miroshnichenko on Pexels

Today's Value-Added Medicines and 505(b)(2) professionals stitch together fragmented advice from five or more siloed events a year — a regulatory webinar here, an IP workshop there, a BD panel somewhere else.

HYBRIDGE is the first industry-led, end-to-end conference that puts ideation, IP, non-clinical, clinical, regulatory (US + EU), market access, BD and licensing in the same room.

Curated by Annion, HYBRIDGE is built on three principles: industry voice over vendor pitch, end-to-end scope over siloed sessions, and a working network of peers who have already done it.

Day 1

Regulatory, clinical, IP and market-access training.

Day 2

Industry experience, technologies, licensing round tables.

Network

Evening event with leading operators and partners.